跳到主要內容
Quest Diagnostics Home.

關節炎和類風濕性關節炎

關節炎檢測:從診斷到預後和監測

We understand arthritis is one of the main reasons patients may find themselves in your office. In fact, arthritis affects more than 20% of American adults—over 50 million people. It is also one of the most common health complaints in the United States, and the leading cause of disability.1,2

\r\n

That’s why Quest Diagnostics is committed to helping you quickly identify the source of your patients’ symptoms, allowing you to speed treatment and minimize the impact of disease. From first-line tests to monitoring, turn to Quest for the right test for the right patient at the right time.

\r\n","@type":"corporate/components/text"}}" id="text-86b2e81247" class="cmp-text">

我們理解關節炎是患者可能在您的辦公室中發現自己的主要原因之一。事實上,關節炎影響超過20%的美國成人 - 超過5000萬人。它也是美國最常見的健康投訴之一,以及殘疾的主要原因。1,2

這就是為什麼Quest Diagnostics致力於幫助您快速識別患者症狀的來源,讓您迅速處理並最大限度地減少疾病的影響。從一線測試到監控,轉向追求正確的患者的正確測試。


14-3-3η(ETA)蛋白質:創新洞察力

More than 100 different diseases fall under the umbrella term “arthritis.”3 Their symptoms can be similar, making diagnosis challenging—and speed to diagnosis critical—to ensure timely management of symptoms and disease progression. Our growing portfolio of tests can help you distinguish between different forms of arthritis, speeding diagnosis and time to treatment.

\r\n","@type":"corporate/components/text"}}" id="text-58c2d32112" class="cmp-text">

超過100種不同的疾病落在傘期“關節炎”下。3.它們的症狀可以是相似的,使診斷挑戰性和速度診斷至關重要 - 以確保及時管理症狀和疾病進展。我們越來越多的測試組合可以幫助您區分不同形式的關節炎,超速診斷和時間來治療。

At Quest, we’re driven by innovation. Our testing evaluates some of the newest tools for diagnosis—like the 14-3-3η (eta) protein, a predictor of early inflammation for rheumatoid arthritis (RA) and erosive psoriatic arthritis (PsA). This protein is released into synovial fluid and blood when there is inflammation associated with joint erosion and may play a biologic role in the erosive process. Blood levels appear elevated in patients with RA and PsA, but not in other diseases.4
\r\n

\r\n

A test for the 14-3-3η protein is available from Quest Diagnostics as an individual biomarker, as well as within our comprehensive panels. If RA and PsA are diagnosed early (ie, before significant joint erosion occurs), treatment can help to prevent irreversible damage. 

\r\n","@type":"corporate/components/text"}}" id="text-d5418b87cd" class="cmp-text">

在任務時,我們是由創新驅動的。我們的測試評估一些最新的診斷工具,用於診斷為14-3-3η(ETA)蛋白,是類風濕性關節炎(Ra)和腐蝕性銀屑病關節炎(PSA)的早期炎症的預測因素。當存在與關節侵蝕相關的炎症時,該蛋白質被釋放到滑膜液和血液中,並且可能在腐蝕過程中發揮生物學作用。血液水平呈現出Ra和PSA患者升高,但不在其他疾病中升高。4.

為單個生物標誌物以及在我們的綜合麵板中,可以從Quest Diagnostics獲得14-3-3蛋白的測試。如果RA和PSA早期診斷(即發生顯著的關節侵蝕),則治療可以有助於防止不可逆的損害。


綜合關節炎和類風濕性關節炎測試組合

早期治療類風濕性關節炎,以幫助緩慢侵蝕

\r\nRheumatoid arthritis (RA)—the inflammatory “flaring” arthritis—is a systemic autoimmune disease. Approximately 165,000 new cases are diagnosed annually in the United States.5 All parts of the body can be affected, including the heart and lungs, but RA is often characterized by symmetrical finger and wrist pain. One of the most potentially devastating forms of arthritis, it typically appears in the third and fourth decades of life and affects women more frequently than men.

\r\n

Quest offers a full suite of testing for RA, including a test for the 14-3-3η protein biomarker.

\r\n

Rheumatoid arthritis tests:
\r\n

\r\n","@type":"corporate/components/text"}}" id="text-7067800bc7" class="cmp-text">


類風濕性關節炎(RA) - 炎症“耀斑”關節炎 - 是一種全身自身免疫疾病。在美國每年診斷約165,000例新案件。5.身體的所有部位都可以受到影響,包括心髒和肺,但是Ra通常是對稱的手指和手腕疼痛的特征。最潛在毀滅性的關節炎形式之一,它通常出現在生命的第三和第四十年中,並影響女性比男性更頻繁。

任務為RA提供全套測試,包括對14-3-3蛋白生物標誌物的測試。

類風濕性關節炎測試:

*Panel components may be ordered separately.

\r\n","@type":"corporate/components/text"}}" id="text-6628dc908d" class="cmp-text">

*麵板組件可以單獨訂購。

獲得骨關節炎所需的差異診斷

\r\nKnown as the “wear and tear” arthritis, osteoarthritis (OA) is the most common form of arthritis, affecting over 30 million Americans.6

\r\n

Many symptoms of OA and RA overlap, including pain, swelling, and stiffness in the joints. These similarities can cause difficulty when differentiating the diseases. Differential diagnosis of OA and RA is important because treatments differ.7

\r\n

Depending on the joint, classification criteria may include joint symptoms (pain, stiffness, swelling, enlargement, deformation), age, erythrocyte sedimentation rate, radiologic findings (presence of osteophytes or narrowing of joint space), synovial fluid tests (color, appearance, white blood cell count), and the sensation of crackling in the joint (crepitus).8

\r\n

In addition, some laboratory markers are elevated in RA patients but normal in OA patients. A positive or elevated result for rheumatoid factor, cyclic citrullinated peptide antibody, or the 14-3-3η protein may suggest inflammatory arthritis, such as RA, rather than OA.

\r\n

Osteoarthritis tests:

\r\n","@type":"corporate/components/text"}}" id="text-4629462654" class="cmp-text">


被稱為“磨損撕裂”關節炎,骨關節炎(OA)是最常見的關節炎形式,影響超過3000萬美國人。6.

OA和RA重疊的許多症狀,包括關節中的疼痛,腫脹和僵硬。這些相似之處會導致疾病的困難造成困難。OA和RA的差異診斷很重要,因為治療有所不同。7.

根據關節,分類標準可包括關節症狀(疼痛,剛度,腫脹,擴大,變形),年齡,紅細胞沉降率,放射學結果(關節空間的骨折或縮小),滑膜液測試(顏色,外觀,外觀,白細胞計數,以及關節(縐紗)裂紋的感覺。8.

此外,一些實驗室標記物在RA患者中升高,但在OA患者中正常。類風濕因子,環狀瓜氨酸肽抗體或14-3-3蛋白的陽性或升高的結果可以提示炎症性關節炎,例如Ra,而不是OA。

骨關節炎測試

用新興的生物標誌物測試識別銀屑病關節炎

\r\nPsoriatic arthritis (PsA) occurs in about 10% to 20% of people with psoriasis.9 While PsA is similar to RA, it is more serious, because it extends to the joints, ligaments, and tendons.

\r\n

Evaluation of a patient for psoriatic arthritis may include a personal and family history and a physical exam. Helpful laboratory tests include10:

\r\n
    \r\n
  • Rheumatoid factor and cyclic citrullinated peptide antibody to rule out RA
  • \r\n
  • C-reactive protein and/or erythrocyte sedimentation rate to document inflammation
  • \r\n
  • Hemoglobin or CBC to test for anemia
  • \r\n
\r\n

A marker of erosive arthritis in psoriasis: the 14-3-3η protein
\r\n

\r\n

Patients with psoriasis have normal 14-3-3η levels, as do psoriasis patients with nonerosive arthritis. However, patients with erosive psoriatic arthritis may have elevated 14-3-3η. As a result, elevations in 14-3-3η in followed psoriasis patients may herald onset of erosive disease.11 Quest incorporates a longitudinal view of the patient’s 14-3-3η test results for ease of monitoring.

\r\n

Psoriatic arthritis tests:
\r\n  

\r\n","@type":"corporate/components/text"}}" id="text-af70160104" class="cmp-text">


銀屑病關節炎(PSA)發生在約10%至20%的牛皮癬中。9.雖然PSA類似於RA,但它更為嚴重,因為它延伸到關節,韌帶和肌腱。

對銀屑病關節炎患者的評估可能包括個人和家族史和體檢。有用的實驗室測試包括10.

  • 測量RA的類風濕因子和循環瓜氨酸肽抗體
  • C-反應蛋白和/或紅細胞沉降率給予文件炎症
  • 血紅蛋白或CBC測試貧血

牛皮癬中腐蝕性關節炎的標誌物:14-3-3蛋白

牛皮癬患者具有正常的14-3-3米水平,牛皮癬患者是不整理關節炎的患者。然而,患有腐蝕性銀屑病關節炎的患者可能升高14-3-3米。結果,牛皮癬患者的14-3-3米的升高可能導致腐蝕性疾病的先驅。11.任務包括患者的14-3-3米測試結果的縱向視圖,以便於監測。

銀屑病關節炎試驗

The power of Quest
\r\n\r\n","@type":"corporate/components/text"}}" id="text-3b8944ad18" class="cmp-text">

任務的力量

參考

  1. Barbour K,Helmick Cg,無聊M等人。生命的跡象:醫生診斷的關節炎和關節炎遺傳活動患病率 - 美國,2013 - 2015年。mmwr morb mortal wkly代表。2017; 66(9):246-253。DOI:10.15585 / mmwr.mm6609e1
  2. Courtney-Long E,Carroll DD,Zhang QC等。成人美國的殘疾與殘疾型患病率,2013年。MMWR摩托車WKLY REP。2015; 64(29):777-783。DOI:10.15585 / mmwr.mm6429a2
  3. CDC。關節炎類型。2019年2月20日更新。1921年9月3日訪問。https://www.cdc.gov/arritthity/basics/types.html.
  4. Maksymowych WP,Boire G,Van Schaardenburg D等。14-3-3η自身抗體:早期類風濕性關節炎的診斷用途。j類rheumatol.。2015; 42:1587-1594。
  5. Alamanos Y,Voulgari PV,Drosos AA。基於1987年美國風濕病學標準的類風濕性關節炎的發病率和患病率:係統審查。Semin關節炎Rheum.。2006; 36(3):182-188。DOI:10.1016 / J.Semarthrit.2006.08.006
  6. CDC。骨關節炎。2020年7月27日審查。2021年9月3日。http://www.cdc.gov/arritthitis/basics/osteoarthritis.htm.
  7. Hochberg MC,Altman Rd,4月Kt,等。美國風濕病學院2012年推薦用於使用非武渣和藥物治療的手法,臀部和膝關節中的骨關節炎。關節炎護理資源(霍博肯)。2012; 64(4):465-474。DOI:10.1002 / ACR.21596
  8. 獵人DJ,Nevitt M,Losina E等人。骨關節炎的生物標誌物:當前位置和進一步驗證的步驟。最佳實踐Res Clin Rheumatol。2014; 28(1):61-71。DOI:10.1016 / J.BERH.2014.01.007
  9. MESE P.對銀屑病關節炎治療的更新。公牛紐約醫院JT DIS。2012; 70(3):167-171。
  10. 美國風濕病學院。銀屑病關節炎。2019年3月更新。2014年3月19日訪問http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/psoriatic_arthritis/
  11. Maksymowych WP,Naides SJ,Bykerk v等人。血清14-3-3η是一種新的標記,其補充了當前的血清學測量,以增強類風濕性關節炎患者的檢測。j rheumatol。2014;41(11):2104-2113。DOI:10.3899 / Jrheum.131446

Baidu
map